EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

John K Forrest, G Michael Deeb, Steven J Yakubov, Hemal Gada, Mubashir A Mumtaz, Basel Ramlawi, Tanvir Bajwa, Paul S Teirstein, Michael DeFrain, Murali Muppala, Bruce J Rutkin, Atul Chawla und 17 weitere

Journal of the American College of Cardiology · 2023

DOI: 10.1016/j.jacc.2023.02.017 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American College of Cardiology, 2023. Verfasst von John K Forrest und 28 weiteren Autor:innen. Beteiligte Einrichtung: Yale University School of Medicine, New Haven, Connecticut, USA. Electronic address: john.k.forrest@yale.edu. Hauptthemen laut MEDLINE: Aortic Valve Insufficiency, Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement, Heart Valve Prosthesis. Die Arbeit wurde bisher 172-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medtronic Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Randomized data comparing outcomes of transcatheter aortic valve replacement (TAVR) with surgery in low-surgical risk patients at time points beyond 2 years is limited. This presents an unknown for physicians striving to educate patients as part of a shared decision-making process. OBJECTIVES: The authors evaluated 3-year clinical and echocardiographic outcomes from the Evolut Low Risk trial. METHODS: Low-risk patients were randomized to TAVR with a self-expanding, supra-annular valve or surgery. The primary endpoint of all-cause mortality or disabling stroke and several secondary endpoints were assessed at 3 years. RESULTS: There were 1,414 attempted implantations (730 TAVR; 684 surgery). Patients had a mean age of 74 years and 35% were women. At 3 years, the primary endpoint occurred in 7.4% of TAVR patients and 10.4% of surgery patients (HR: 0.70; 95% CI: 0.49-1.00; P = 0.051). The difference between treatment arms for all-cause mortality or disabling stroke remained broadly consistent over time: -1.8% at year 1; -2.0% at year 2; and -2.9% at year 3. The incidence of mild paravalvular regurgitation (20.3% TAVR vs 2.5% surgery) and pacemaker placement (23.2% TAVR vs 9.1% surgery; P < 0.001) were lower in the surgery group. Rates of moderate or greater paravalvular regurgitation for both groups were

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Valve InsufficiencyAortic Valve StenosisTranscatheter Aortic Valve ReplacementHeart Valve ProsthesisStrokeHumansFemaleAgedMaleAortic ValveRisk FactorsTreatment OutcomeProspective Studies

Stichwörter der Autor:innen

aortic stenosislow riskself-expandingsurgical aortic valve replacementtranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Yale University School of Medicine, New Haven, Connecticut, USA. Electronic address: john.k.forrest@yale.edu.
  • University of Michigan Health Systems University Hospital, Ann Arbor, Michigan, USA.
  • OhioHealth Riverside Methodist Hospital, Columbus, Ohio, USA.
  • University of Pittsburgh Medical Center, Harrisburg, Pennsylvania, USA.
  • Lankenau Heart Institute, Philadelphia, Pennsylvania, USA.
  • Aurora St Luke's Medical Center, Milwaukee, Wisconsin, USA.

Förderung

  • Medtronic Inc

Zitieren

APA

Forrest, J. K., Deeb, G. M., Yakubov, S. J., Gada, H., Mumtaz, M. A., Ramlawi, B., Bajwa, T., Teirstein, P. S., DeFrain, M., Muppala, M., Rutkin, B. J., Chawla, A., Jenson, B., Chetcuti, S. J., Stoler, R. C., Poulin, M. F., Khabbaz, K., Levack, M., Goel, K., …, & Low Risk Trial Investigators (2023). 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2023.02.017

Vancouver

Forrest JK, Deeb GM, Yakubov SJ, Gada H, Mumtaz MA, Ramlawi B, et al. 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis. Journal of the American College of Cardiology. 2023. doi:10.1016/j.jacc.2023.02.017

BibTeX
@article{Forrest2023,
  author = {Forrest, John K and Deeb, G Michael and Yakubov, Steven J and Gada, Hemal and Mumtaz, Mubashir A and Ramlawi, Basel and Bajwa, Tanvir and Teirstein, Paul S and DeFrain, Michael and Muppala, Murali and Rutkin, Bruce J and Chawla, Atul and Jenson, Bart and Chetcuti, Stanley J and Stoler, Robert C and Poulin, Marie-France and Khabbaz, Kamal and Levack, Melissa and Goel, Kashish and Tchétché, Didier and Lam, Ka Yan and Tonino, Pim A L and Ito, Saki and Oh, Jae K and Huang, Jian and Popma, Jeffrey J and Kleiman, Neal and Reardon, Michael J and Low Risk Trial Investigators, Low Risk Trial Investigators},
  title = {3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis},
  journal = {Journal of the American College of Cardiology},
  year = {2023},
  doi = {10.1016/j.jacc.2023.02.017}
}
Kostenlos starten →